EA202191106A1 - Пробиотическая добавка для метаболического здоровья, содержащая lactobacillus - Google Patents
Пробиотическая добавка для метаболического здоровья, содержащая lactobacillusInfo
- Publication number
- EA202191106A1 EA202191106A1 EA202191106A EA202191106A EA202191106A1 EA 202191106 A1 EA202191106 A1 EA 202191106A1 EA 202191106 A EA202191106 A EA 202191106A EA 202191106 A EA202191106 A EA 202191106A EA 202191106 A1 EA202191106 A1 EA 202191106A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- metabolic health
- containing lactobacillus
- probiotic supplement
- health containing
- mammalian subject
- Prior art date
Links
- 230000010034 metabolic health Effects 0.000 title abstract 3
- 241000186660 Lactobacillus Species 0.000 title abstract 2
- 229940039696 lactobacillus Drugs 0.000 title abstract 2
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- 239000013589 supplement Substances 0.000 title 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
В заявке раскрыты штаммы Lactobacillus, оказывающие благоприятное влияние на метаболическое здоровье субъекта-млекопитающего. Дополнительно раскрыты композиции, содержащие такие штаммы, и их применение для улучшения метаболического здоровья или для снижения уровня глюкозы в крови у субъекта-млекопитающего.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18202187 | 2018-10-24 | ||
PCT/EP2019/079027 WO2020084051A1 (en) | 2018-10-24 | 2019-10-24 | Probiotic supplement for metabolic health comprising lactobacillus |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202191106A1 true EA202191106A1 (ru) | 2021-07-20 |
Family
ID=64277485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202191106A EA202191106A1 (ru) | 2018-10-24 | 2019-10-24 | Пробиотическая добавка для метаболического здоровья, содержащая lactobacillus |
Country Status (12)
Country | Link |
---|---|
US (2) | US11963986B2 (ru) |
EP (1) | EP3870197A1 (ru) |
JP (1) | JP2022506081A (ru) |
KR (1) | KR20220008252A (ru) |
CN (1) | CN113164533B (ru) |
AU (1) | AU2019365399A1 (ru) |
BR (1) | BR112021007811A8 (ru) |
CA (1) | CA3116566A1 (ru) |
EA (1) | EA202191106A1 (ru) |
IL (1) | IL282382A (ru) |
MX (1) | MX2021004554A (ru) |
WO (1) | WO2020084051A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7179424B2 (ja) * | 2019-03-20 | 2022-11-29 | 日清食品ホールディングス株式会社 | Glp-1分泌促進能を有する乳酸菌 |
CN116200310B (zh) * | 2023-03-17 | 2024-01-30 | 微康益生菌(苏州)股份有限公司 | 一种调节肠道激素glp-1水平的益生菌剂及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200802935B (en) * | 2005-10-06 | 2009-11-25 | Brobi Ab | Use of lactobacillus for treatment of autoimmune diseases |
BRPI0616962B8 (pt) | 2005-10-06 | 2021-05-25 | Probi Ab | uso de lactobacillus para o tratamento de doenças autoimunes |
DE102005062731A1 (de) * | 2005-12-22 | 2007-06-28 | Organobalance Gmbh | Neue Lactobacillus Stämme und deren Verwendung |
EP2269465A1 (en) | 2006-05-03 | 2011-01-05 | Probiotical S.p.a. | Compositions comprising Bifidobacterium adolescentis |
TWI346554B (en) | 2008-04-30 | 2011-08-11 | Genmont Biotech Inc | Lactobacillus isolates having anti-inflammatory activities and uses of the same |
EP2392340B1 (en) | 2010-06-01 | 2014-01-08 | GenMont Biotech Inc. | Novel lactobacillus strain, composition and use thereof for treating diabetes |
US8298526B2 (en) | 2010-06-02 | 2012-10-30 | Genmont Biotech Inc. | Lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof |
CN102935092B (zh) | 2010-06-09 | 2014-03-26 | 景岳生物科技股份有限公司 | 新颖乳杆菌及其组合物和在制备改善糖尿病及其并发症药物中的应用 |
BR112013031325A2 (pt) | 2011-06-08 | 2017-06-06 | Organobalance Gmbh | cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori |
PT2898061T (pt) * | 2012-09-20 | 2020-02-14 | Prothera Inc | Composições probióticas para o tratamento da obesidade e de condições relacionadas com a obesidade |
EP2953476B1 (en) | 2013-02-07 | 2020-01-01 | Novozymes A/S | Use of skim milk as a carrier for a composition comprising lactobacillus |
WO2015068809A1 (ja) | 2013-11-07 | 2015-05-14 | サントリーホールディングス株式会社 | 乳酸菌を含む腸管バリア機能亢進剤 |
US20150196608A1 (en) * | 2014-01-10 | 2015-07-16 | Genmont Biotech Inc. | Lactobacillus reuteri gmnl-263 composition for controlling body weight and its use thereof |
GB2522188B (en) * | 2014-01-10 | 2016-09-21 | Genmont Biotech Inc | A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof |
US9301983B2 (en) | 2014-03-07 | 2016-04-05 | Genmont Biotech Inc. | Composition and method of Lactobacillus reuteri GMNL-89 in treating type 2 diabetes |
DK3387156T3 (da) * | 2015-12-11 | 2020-08-03 | Prec Group Limited | Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme |
CN107375344A (zh) | 2017-07-06 | 2017-11-24 | 南昌大学 | 植物乳杆菌zdy2013的新应用 |
KR101864347B1 (ko) | 2017-09-06 | 2018-06-05 | 주식회사 지놈앤컴퍼니 | 락토바실러스 람노수스 lm1019 균주 및 이를 포함하는 비만 또는 당뇨병 예방 및 치료용 조성물 |
-
2019
- 2019-10-24 MX MX2021004554A patent/MX2021004554A/es unknown
- 2019-10-24 CA CA3116566A patent/CA3116566A1/en active Pending
- 2019-10-24 BR BR112021007811A patent/BR112021007811A8/pt unknown
- 2019-10-24 WO PCT/EP2019/079027 patent/WO2020084051A1/en unknown
- 2019-10-24 AU AU2019365399A patent/AU2019365399A1/en active Pending
- 2019-10-24 KR KR1020217014958A patent/KR20220008252A/ko active Search and Examination
- 2019-10-24 EA EA202191106A patent/EA202191106A1/ru unknown
- 2019-10-24 EP EP19797200.3A patent/EP3870197A1/en active Pending
- 2019-10-24 CN CN201980070200.5A patent/CN113164533B/zh active Active
- 2019-10-24 US US17/287,719 patent/US11963986B2/en active Active
- 2019-10-24 JP JP2021523240A patent/JP2022506081A/ja active Pending
-
2021
- 2021-04-18 IL IL282382A patent/IL282382A/en unknown
-
2024
- 2024-03-27 US US18/618,941 patent/US20240238354A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20220008252A (ko) | 2022-01-20 |
BR112021007811A8 (pt) | 2022-08-30 |
CN113164533B (zh) | 2024-10-18 |
US20240238354A1 (en) | 2024-07-18 |
EP3870197A1 (en) | 2021-09-01 |
US11963986B2 (en) | 2024-04-23 |
JP2022506081A (ja) | 2022-01-17 |
WO2020084051A1 (en) | 2020-04-30 |
MX2021004554A (es) | 2022-01-18 |
CN113164533A (zh) | 2021-07-23 |
BR112021007811A2 (pt) | 2021-07-27 |
IL282382A (en) | 2021-06-30 |
AU2019365399A1 (en) | 2021-04-22 |
CA3116566A1 (en) | 2020-04-30 |
US20210393712A1 (en) | 2021-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017014787A (es) | Poblaciones bacterianas para promover la salud. | |
EA201790405A1 (ru) | Композиции и способы лечения метаболических расстройств | |
WO2016086210A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | |
EA201692477A1 (ru) | Композиции и способы применения для лечения метаболических расстройств | |
MX2024011127A (es) | Bacterias acidolacticas novedosas y uso de las mismas. | |
SG10201903823QA (en) | Methods and compositions relating to microbial treatment and diagnosis of disorders | |
PH12017502181A1 (en) | Nutritional compositions containing an elevated level of inositol and uses thereof | |
MX2022011742A (es) | Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados. | |
EA201992175A1 (ru) | Композиции и способы, включающие пробиотические молекулы | |
MX2018002543A (es) | Composiciones que comprenden compuestos de urolitina. | |
PH12017502042A1 (en) | Dietary supplement | |
PH12020550217A1 (en) | Nutrient-spore formulations and uses thereof | |
EA202191106A1 (ru) | Пробиотическая добавка для метаболического здоровья, содержащая lactobacillus | |
MY197917A (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
EA202090728A1 (ru) | Применение нор-урсодезоксихолевой кислоты для снижения печеночного жира | |
MX2023008729A (es) | Tratamiento de colangiopatías con seladelpar. | |
BR112022006012A2 (pt) | Formulações de trealose e usos das mesmas | |
MX2021005669A (es) | Metodos para mejorar la salud metabolica en un animal. | |
UA121198U (uk) | Композиція для лікування і профілактики захворювань печінки | |
UA99380U (ru) | Способ применения пробиотиков для сельскохозяйственных животных | |
UA104696U (ru) | Способ прогнозирования течения q-инфаркта миокарда на фоне недифференцированной дисплазии соединительной ткани | |
TN2014000475A1 (en) | Probiotic producing lactic acid bacteria from freshwater fish | |
UA97668U (xx) | Склад вареників "сирні з курагою" геродієтичного призначення | |
UA93905U (uk) | Пробіотик "субалін" |